San Francisco, California, July 27, 2017: The growing demand for spectrometry instruments for drug development and quality control is driving the growth of the global molecular spectrometry market, states TMR Research in its latest report. The report is titled “Molecular Spectrometry Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025.” The growing investments by various leading players from the healthcare industry for the research and development of new technology are boosting the progress of the molecular spectrometry market. Increasing concerns for food and safety will also help increase the demand for molecular spectrometry. The report details on these and other factors aiding the growth of this market.
The market also faces various challenges and threats. These challenges need to be overcome and thus the report enlists them and discusses each of the restraining factors so that readers and new investors are well informed about what they may have to encounter. The details about the challenging factors also help established players to re-align their strategies and find ways of overcoming these challenges. The cost of molecular spectrometry instruments is high and may act as a growth inhibitor during the forecast period from 2017 to 2025. In addition to this, the need for skilled operators will be felt. As there is a lack of skilled operators, especially in developing nations, the global molecular spectrometry instruments market could suffer.
The report segments the market on the basis of geography into four key regions. These include: Asia Pacific, North America, Europe, and the Rest of the World. Of these, North America is leading in the molecular spectrometry instruments market. Key contributors to the revenue of this market within the North American region include Canada and the U.S. As these nations have highly developed healthcare infrastructure and high funding for research and development, the molecular spectrometry instruments market is benefitting. These nations also receive sponsorships from national level research institutes and government agencies which are fueling the growth of the market in the region. Apart from North America, Asia Pacific is anticipated to be promising for the molecular spectrometry instruments market. The growing penetration of research centers and pharmaceutical companies in developing nations of Asia Pacific, such as India will prove to be lucrative for the growth of the molecular spectrometry instruments market.
Key companies mentioned in the report include: Agilent Technologies, Shimadzu Corporation, Bruker Corporation, FOSS Company, JASCO International Co., Ltd., PerkinElmer, Inc., and Shimadzu Corporation.